HealthEquity, Inc.

NasdaqGS:HQY Rapport sur les actions

Capitalisation boursière : US$6.5b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

HealthEquity Gestion

Gestion contrôle des critères 3/4

HealthEquity's CEO is Jon Kessler, appointed in Feb 2014, has a tenure of 10.5 years. total yearly compensation is $13.45M, comprised of 5.2% salary and 94.8% bonuses, including company stock and options. directly owns 0.39% of the company’s shares, worth $25.12M. The average tenure of the management team and the board of directors is 2.8 years and 7.5 years respectively.

Informations clés

Jon Kessler

Directeur général

US$13.4m

Rémunération totale

Pourcentage du salaire du PDG5.2%
Durée du mandat du directeur général10.5yrs
Propriété du PDG0.4%
Durée moyenne d'occupation des postes de direction2.8yrs
Durée moyenne du mandat des membres du conseil d'administration7.5yrs

Mises à jour récentes de la gestion

We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation

Jun 21
We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation

Recent updates

Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

Jul 13
Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation

Jun 21
We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation

Earnings Beat: HealthEquity, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jun 07
Earnings Beat: HealthEquity, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

HealthEquity: A Trading Vehicle Performing As Expected, Strong Growth Hard To Ignore

Jun 04

HealthEquity: Strong Growth And Healthy Cash Flows Changed My Mind

May 29

Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?

May 03
Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?

Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues

Apr 11
Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues

HealthEquity: Multiple Compression Has Finally Made It A Buy

Mar 21

Investors Appear Satisfied With HealthEquity, Inc.'s (NASDAQ:HQY) Prospects

Dec 28
Investors Appear Satisfied With HealthEquity, Inc.'s (NASDAQ:HQY) Prospects

Is HealthEquity (NASDAQ:HQY) A Risky Investment?

Nov 17
Is HealthEquity (NASDAQ:HQY) A Risky Investment?

HealthEquity, Inc.'s (NASDAQ:HQY) Intrinsic Value Is Potentially 51% Above Its Share Price

Oct 26
HealthEquity, Inc.'s (NASDAQ:HQY) Intrinsic Value Is Potentially 51% Above Its Share Price

Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

Jul 27
Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jul 07
HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 37% Below Their Intrinsic Value Estimate

Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

Apr 18
Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

Estimating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

Mar 14
Estimating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

Dec 24
Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Dec 02
Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Is HealthEquity, Inc. (NASDAQ:HQY) Expensive For A Reason? A Look At Its Intrinsic Value

Nov 11
Is HealthEquity, Inc. (NASDAQ:HQY) Expensive For A Reason? A Look At Its Intrinsic Value

These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

Sep 08
These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

HealthEquity Non-GAAP EPS of $0.33 in-line, revenue of $206.1M beats by $2.22M

Sep 06

HealthEquity: Asymmetry In Valuation Continues To Widen

Aug 25

HealthEquity COO steps down, CEO to assume his responsibilities

Aug 02

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Jul 27
Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Calculating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

Jul 06
Calculating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

May 24
These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Apr 12
Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

An Intrinsic Calculation For HealthEquity, Inc. (NASDAQ:HQY) Suggests It's 29% Undervalued

Mar 16
An Intrinsic Calculation For HealthEquity, Inc. (NASDAQ:HQY) Suggests It's 29% Undervalued

HealthEquity: Quality Firm, But Not Likely Worth The Price

Mar 01

These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

Jan 28
These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Jan 02
Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 26% Below Their Intrinsic Value Estimate

Dec 09
HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 26% Below Their Intrinsic Value Estimate

Analyse de la rémunération des PDG

Comment la rémunération de Jon Kessler a-t-elle évolué par rapport aux bénéfices de HealthEquity?
DateRémunération totaleSalaireBénéfices de l'entreprise
Apr 30 2024n/an/a

US$80m

Jan 31 2024US$13mUS$700k

US$56m

Oct 31 2023n/an/a

US$29m

Jul 31 2023n/an/a

US$13m

Apr 30 2023n/an/a

-US$8m

Jan 31 2023US$13mUS$700k

-US$26m

Oct 31 2022n/an/a

-US$59m

Jul 31 2022n/an/a

-US$62m

Apr 30 2022n/an/a

-US$55m

Jan 31 2022US$10mUS$700k

-US$44m

Oct 31 2021n/an/a

-US$6m

Jul 31 2021n/an/a

US$723k

Apr 30 2021n/an/a

US$4m

Jan 31 2021US$9mUS$667k

US$9m

Oct 31 2020n/an/a

US$3m

Jul 31 2020n/an/a

-US$20m

Apr 30 2020n/an/a

-US$332k

Jan 31 2020US$5mUS$500k

US$40m

Oct 31 2019n/an/a

US$53m

Jul 31 2019n/an/a

US$90m

Apr 30 2019n/an/a

US$93m

Jan 31 2019US$5mUS$483k

US$74m

Oct 31 2018n/an/a

US$67m

Jul 31 2018n/an/a

US$61m

Apr 30 2018n/an/a

US$56m

Jan 31 2018US$4mUS$400k

US$47m

Rémunération vs marché: Jon's total compensation ($USD13.45M) is above average for companies of similar size in the US market ($USD8.39M).

Rémunération et revenus: Jon's compensation has been consistent with company performance over the past year.

PDG

Jon Kessler (56 yo)

10.5yrs

Titularisation

US$13,448,018

Compensation

Mr. Jon Kessler is a Member of the Board of Managers at HealthEquity Advisors, LLC. He has been the Chief Executive Officer and President of HealthEquity, Inc. since February 2014. Mr. Kessler founded Wage...

Équipe de direction

NomPositionTitularisationCompensationPropriété
Jon Kessler
President10.5yrsUS$13.45m0.39%
$ 25.1m
Stephen Neeleman
Founder & Vice Chairman21.8yrsUS$3.04m0.95%
$ 61.7m
James Lucania
CFO & Executive VPless than a yearUS$5.23mpas de données
Elimelech Rosner
Executive VP & CTO2.4yrsUS$4.81m0.014%
$ 920.6k
Delano Ladd
Executive VP7.9yrsUS$2.64m0.044%
$ 2.8m
Richard Putnam
Vice President of Investor Relationsno datapas de donnéespas de données
Steve Lindsay
Executive Vice President of Sales & Relationship Management3yrspas de donnéespas de données
Brad Bennion
Executive Vice President of Corporate Development & Strategy7.3yrspas de donnéespas de données
Tia Padia
Executive VP & Chief Marketing Officer2.6yrspas de donnéespas de données
Cheryl King
Executive VP & Chief People Officer1.3yrspas de donnéespas de données
Kamesh Tumsi
Senior VP & Head of Product1.8yrspas de donnéespas de données
Selim Aissi
Executive VP & Chief Security Officerno datapas de donnéespas de données

2.8yrs

Durée moyenne de l'emploi

56yo

Âge moyen

Gestion expérimentée: HQY's management team is considered experienced (2.8 years average tenure).

Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Jon Kessler
President15.4yrsUS$13.45m0.39%
$ 25.1m
Stephen Neeleman
Founder & Vice Chairman21.8yrsUS$3.04m0.95%
$ 61.7m
Adrian Dillon
Independent Director7.9yrsUS$297.50k0.062%
$ 4.1m
Robert Selander
Independent Non-Executive Chairman8.9yrsUS$362.50k0.052%
$ 3.4m
Paul Black
Independent Director1.9yrsUS$272.50k0.0050%
$ 329.0k
Evelyn Dilsaver
Independent Director10yrsUS$290.00k0.037%
$ 2.4m
Stuart Parker
Independent Director3.7yrsUS$280.00k0.035%
$ 2.3m
Gayle Wellborn
Independent Director7yrsUS$278.87k0.017%
$ 1.1m
Debra McCowan
Independent Director6.3yrsUS$275.00k0.012%
$ 766.2k
Rajesh Natarajan
Independent Director2.3yrsUS$272.50k0.0097%
$ 628.7k

7.5yrs

Durée moyenne de l'emploi

62.5yo

Âge moyen

Conseil d'administration expérimenté: HQY's board of directors are considered experienced (7.5 years average tenure).